T. Rowe Price Investment Management, Inc. Immunome Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,516,454 shares of IMNM stock, worth $22.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,516,454Holding current value
$22.7 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
106Shares Held
32.1MCall Options Held
46.1KPut Options Held
32.5K-
Redmile Group, LLC San Francisco, CA4.89MShares$73 Million4.76% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$58 Million2.73% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.25MShares$33.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$30.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.64MShares$24.5 Million0.1% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $181M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...